The Clinicopathological Characteristics and Prognosis of Cholangiolocarcinoma: A Multicenter Study With a Central Pathology Review
Journal of Hepato-Biliary-Pancreatic Sciences · 2026-10 · 33 (10) · 758-768
DOI: 10.1002/jhbp.70170 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 14.08.2026. Verfasst von Takamichi Ishii und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Abstract (Originalsprache)
Background
Cholangiolocarcinoma (CLC) is a rare liver cancer with ≥ 80% ductular configuration (DC). Given its rarity, its clinicopathological characteristics remain poorly understood, and its status as a distinct disease entity remains controversial. We conducted a nationwide multicenter study with centralized pathological review to investigate the features of CLC.
Methods
We included patients with a postoperative diagnosis of CLC at 49 participating institutions (2005–2018). All cases were re‐evaluated by centralized pathology according to the WHO classification.
Results
Among 196 re‐evaluated patients, 56 tumors were classified as CLC, 69 as intrahepatic cholangiocarcinoma (iCCA) with < 80% DC, 53 as small‐duct type iCCA with DC, and 16 as mixed small‐ and large‐duct type (SD/LD‐iCCA with DC). CLC showed a low prevalence of viral hepatitis (23.2%), frequent arterial enhancement (83.9%), and characteristic apical EMA positivity. The median overall survival (OS) was 10.8 years, with 5‐ and 10‐year OS rates of 85.0% and 73.7%, respectively, which were significantly better than those of SD/LD‐iCCA with DC. Recurrence occurred in 38.2% of CLC cases with favorable outcomes following surgical resection.
Conclusions
CLC exhibits distinct pathological and prognostic features, including favorable long‐term survival, supporting CLC as a distinct clinicopathological entity. Further molecular research is needed to refine the classification. Trial Registration This study was registered with the UMIN Clinical Trials Registry (UMIN000057919)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Surgery for Abdominal Oncology and Organ Regeneration, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Pathology, International University of Health and Welfare School of Medicine, IUHW Narita Hospital, Narita, Japan.
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
- Department of Hepato-Biliary-Pancreatic Surgery, Kyorin University Hospital, Mitaka, Japan.
- Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.
ORCID-Profile: Takamichi Ishii, Kenta Makino, Etsuro Hatano, Mina Komuta, Yoshihiro Sakamoto, Yutaka Takeda, Akira Shimizu, Daisuke Asano, Naoto Gotohda
Förderung
- Japan Society for the Promotion of Science
- Japanese Society of Hepato-Biliary-Pancreatic Surgery
Zitieren
APA
Ishii, T., Makino, K., Hatano, E., Komuta, M., Akiba, J., Sakamoto, Y., Ariizumi, S. I., Honda, G., Hisaka, T., Takeda, Y., Shimizu, A., Yasuchika, K., Mizuno, T., Asano, D., Fujio, A., Gotohda, N., Kitami, C., Amaya, K., Sadamori, H., …, & Endo, I. (2026). The Clinicopathological Characteristics and Prognosis of Cholangiolocarcinoma: A Multicenter Study With a Central Pathology Review. Journal of Hepato-Biliary-Pancreatic Sciences, 33(10), 758-768. https://doi.org/10.1002/jhbp.70170
Vancouver
Ishii T, Makino K, Hatano E, Komuta M, Akiba J, Sakamoto Y, et al. The Clinicopathological Characteristics and Prognosis of Cholangiolocarcinoma: A Multicenter Study With a Central Pathology Review. Journal of Hepato-Biliary-Pancreatic Sciences. 2026;33(10):758-768. doi:10.1002/jhbp.70170
BibTeX
@article{Ishii2026,
author = {Ishii, Takamichi and Makino, Kenta and Hatano, Etsuro and Komuta, Mina and Akiba, Jun and Sakamoto, Yoshihiro and Ariizumi, Shun-Ichi and Honda, Goro and Hisaka, Toru and Takeda, Yutaka and Shimizu, Akira and Yasuchika, Kentaro and Mizuno, Takashi and Asano, Daisuke and Fujio, Atsushi and Gotohda, Naoto and Kitami, Chie and Amaya, Koji and Sadamori, Hiroshi and Kawai, Manabu and Nakakura, Akiyoshi and Nakamura, Masafumi and Endo, Itaru},
title = {The Clinicopathological Characteristics and Prognosis of Cholangiolocarcinoma: A Multicenter Study With a Central Pathology Review},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2026},
volume = {33},
number = {10},
pages = {758--768},
doi = {10.1002/jhbp.70170}
}
EUVIMED